HLL Lifecare, a leading manufacturer of contraceptives and allied products, will soon launch simple and cost-effective urine-based fertility measuring kits.

The kit will be commercially available in the market within the next 24 months, according to Dr K. R. S. Krishnan, Head – R&D, HLL Lifecare.

The National Institute for Research in Reproductive Health (NIRRH), an affiliate of the Indian Council of Medical Research (ICMR), has developed the relevant technology.

The ICMR transferred the same to HLL Lifecare for validation, commercialisation and marketing of kits, a spokesman for HLL Lifecare said here.

The technology itself was developed by Dr M. I. Khatkhatay and Dr Meena Desai of NIRRH as part of a project funded by the Department of Biotechnology (DBT), Government of India.

Biotech Consortium India Ltd (BCIL), a technical arm of DBT, helped formalise the transfer. It involves global exclusive and perpetuating rights for manufacture, marketing and sale of the kit.

COST-EFFECTIVE

The tri-partite technology transfer agreement was signed recently in the presence of Dr. V. M. Katoch, Secretary, Department of Health Research, and Director-General, ICMR, at the ICMR Headquarters in New Delhi.

Apart from Dr Krishnan, Dr Poornima Sharma, Chief Executive Officer of BCIL and Dr Sanjiva D. Kholkute, Director of NIRRH, were signatories to the agreement.

The urine-based kit would have four simple and cost-effective technology, based on enzyme linked immune-sorbent assay (Elisa), the HLL Lifecare spokesman said.

It is essential that fruits of public-funded research should reach the society in an affordable manner, said Dr Katoch of ICMR.

MORE MEANINGFUL

Being a Central PSU under the Health Ministry, HLL is well equipped for such a mission. That makes the technology transfer agreement more meaningful, he added.

According to Mr M. Ayyappan, Chairman and Managing Director, HLL Lifecare, the company has always been in the forefront to offer affordable and accessible reproductive healthcare solutions.

HLL Lifecare will take up mass production and marketing of the urine-based fertility test kit for measurement of four key reproductive hormones of four principal metabolites, the spokesman said.

comment COMMENT NOW